Abstract
Pre-eclampsia (PE) is a serious pregnancy complication defined as hypertension combined with proteinuria. Previous report has indicated that the expression of connective tissue growth factor (CTGF) is upregulated in PE placentas. In this study, we aim to investigate the potential association between the methylation of the CTGF promoter and PE. The methylation status of CTGF promoter was assessed by methylation-specific PCR and the expression of CTGF was analyzed by real-time quantitative PCR and immunohistochemistry staining, in placental samples from PE patients and normal pregnant women. The methylation level of the CTGF promoter was also analyzed in peripheral blood DNA samples from 90 PE patients and 94 normal pregnant women and further confirmed by methylation-sensitive restriction enzyme digestion combined with real-time PCR. We found a decreased methylation rate of CTGF promoter in PE placentas compared with normal control. In addition, the frequency of hemimethylated (UM) promoter of CTGF in peripheral blood was significantly lower in the PE group (P = 0.019), while the frequency of overall methylated (MU + MM) promoter of CTGF in peripheral blood was lower (borderline significance P = 0.043) in the PE group. The percentage of methylated CpG in CTGF promoter was 30% lower in maternal blood of PE subjects than in controls. Moreover, the lower methylation frequency of CTGF promoter was in accordance with the higher expression of CTGF in trophoblast cells. Together, our data suggested an association between PE and the hypomethylation of CTGF promoter both in placentas and peripheral blood from a Chinese Han population.
Similar content being viewed by others
Abbreviations
- PE:
-
Pre-eclampsia
- CTGF:
-
Connective tissue growth factor
- BP:
-
Blood pressure
- PCR:
-
Polymerase chain reaction
- MSP:
-
Methylation-specific PCR
References
Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet. 2016;387:999–1011.
Oyston CJ, Stanley JL, Baker PN. Potential targets for the treatment of preeclampsia. Expert Opin Ther Targets. 2015;19:1517–30.
Phipps E, Prasanna D, Brima W, Jim B. Preeclampsia: updates in pathogenesis, definitions, and guidelines. Clin J Am Soc Nephrol. 2016;11:1102–13.
Januar V, Desoye G, Novakovic B, Cvitic S, Saffery R. Epigenetic regulation of human placental function and pregnancy outcome: considerations for causal inference. Am J Obstet Gynecol. 2015;213:S182–96.
Vaiman D. Genes, epigenetics and miRNA regulation in the placenta. Placenta. 2017;52:127–33.
Redman CW, Staff AC. Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity. Am J Obstet Gynecol. 2015;213:S9 e1, S9–11.
Hod T, Cerdeira AS, Karumanchi SA. Molecular mechanisms of preeclampsia. Cold Spring Harb Perspect Med. 2015;5:a023473.
Ramazani Y, Knops N, Elmonem MA, et al. Connective tissue growth factor (CTGF) from basics to clinics. Matrix Biol. 2018;68–69:44–66.
Winterhager E, Gellhaus A. The role of the CCN family of proteins in female reproduction. Cell Mol Life Sci. 2014;71:2299–311.
Oh SY, Song SE, Seo ES, et al. The expression of connective tissue growth factor in pregnancies complicated by severe preeclampsia or fetal growth restriction. Placenta. 2009;30:981–7.
Brown MA, Magee LA, Kenny LC, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72:24–43.
Ungvari Z, Valcarcel-Ares MN, Tarantini S, Yabluchanskiy A, Fülöp GA, Kiss T, et al. Connective tissue growth factor (CTGF) in age-related vascular pathologies. Geroscience. 2017;39:491–8.
Kubota S, Takigawa M. Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions. Clin Sci (Lond). 2015;128:181–96.
Barreto SC, Ray A, Ag EP. Biological characteristics of CCN proteins in tumor development. J BUON. 2016;21:1359–67.
Ponticos M. Connective tissue growth factor (CCN2) in blood vessels. Vasc Pharmacol. 2013;58:189–93.
Rimon E, Chen B, Shanks AL, Nelson DM, Sadovsky Y. Hypoxia in human trophoblasts stimulates the expression and secretion of connective tissue growth factor. Endocrinology. 2008;149:2952–8.
Waddell JM, Evans J, Jabbour HN, Denison FC. CTGF expression is up-regulated by PROK1 in early pregnancy and influences HTR-8/Svneo cell adhesion and network formation. Hum Reprod. 2011;26:67–75.
Das MK, Basak S, Ahmed MS, Attramadal H, Duttaroy AK. Connective tissue growth factor induces tube formation and IL-8 production in first trimester human placental trophoblast cells. Eur J Obstet Gynecol Reprod Biol. 2014;181:183–8.
Shi C, Li G, Tong Y, Deng Y, Fan J. Role of CTGF gene promoter methylation in the development of hepatic fibrosis. Am J Transl Res. 2016;8:125–32.
Welch MD, Greene WK, Kees UR. Hypomethylation of the CTGF gene locus is a common feature of paediatric pre-B acute lymphoblastic leukaemia. Br J Haematol. 2013;162:537–41.
Zhang H, Cai X, Yi B, Huang J, Wang J, Sun J. Correlation of CTGF gene promoter methylation with CTGF expression in type 2 diabetes mellitus with or without nephropathy. Mol Med Rep. 2014;9:2138–44.
Kikuchi R, Tsuda H, Kanai Y, Kasamatsu T, Sengoku K, Hirohashi S, et al. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer. Cancer Res. 2007;67:7095–105.
Zhao LK, Wang Q, Zhang CM, Huang CB. Genome-wide DNA methylation analysis of articular chondrocytes identifies TRAF1, CTGF, and CX3CL1 genes as hypomethylated in osteoarthritis. Clin Rheumatol. 2017;36:2335–42.
Chiba T, Yokosuka O, Fukai K, Hirasawa Y, Tada M, Mikata R, et al. Identification and investigation of methylated genes in hepatoma. Eur J Cancer. 2005;41:1185–94.
Sahai K, Saraswathy S, Yadav TP, Arora D, Krishnan M. Pre-eclampsia: molecular events to biomarkers. Med J Armed Forces India. 2017;73:167–74.
Kumar N, Singh AK. Cell-free fetal DNA: a novel biomarker for early prediction of pre-eclampsia and other obstetric complications. Curr Hypertens Rev. 2018;14:1.
Munoz-Hernandez R, Medrano-Campillo P, Miranda ML, et al. Total and fetal circulating cell-free DNA, angiogenic, and antiangiogenic factors in preeclampsia and hellp syndrome. Am J Hypertens. 2017;30:673–82.
Qi YH, Teng F, Zhou Q, et al. Unmethylated-maspin DNA in maternal plasma is associated with severe preeclampsia. Acta Obstet Gynecol Scand. 2015;94:983–8.
Tsui DW, Chan KC, Chim SS, Chan LW, Leung TY, Lau TK, et al. Quantitative aberrations of hypermethylated RASSF1a gene sequences in maternal plasma in pre-eclampsia. Prenat Diagn. 2007;27:1212–8.
Funding
This work was supported by funding from the National Natural Science Foundation of China [No. 81600211], the Natural Science Foundation of Shandong Province [ZR2014HP017], and the Application and Basic Research Project of Qingdao [18-2-2-27-jch].
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of the Affiliated Hospital of Qingdao University and written consent was obtained from all of the pregnancies before the collection of the placenta and blood.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhang, L., Zhao, F., Yang, C. et al. Hypomethylation of CTGF Promoter in Placenta and Peripheral Blood of Pre-eclampsia Women. Reprod. Sci. 27, 468–476 (2020). https://doi.org/10.1007/s43032-019-00038-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43032-019-00038-z